02509.HK
Qyuns Therapeutics Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 16.44
−1.73%Jul 30, 2026, 02:01 UTC
Caldera Therapeutics obtained commitments for a concurrent private placement of approximately $278 million from a syndicate of leading healthcare institutional investors and mutual funds to support the proposed merger.
Source:Jul 30, 2026, 02:01 UTC
Caldera Therapeutics entered into a definitive merger agreement for an all-stock merger with Synlogic, becoming wholly owned subsidiaries of a new holding company, and the combined company will operate as Caldera Therapeutics, Inc. and list on Nasdaq under ticker CALD.
Source: